Decibel Therapeutics, Inc. Depreciation and Amortization
Decibel Therapeutics, Inc. reported Depreciation and Amortization of $1.50 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2023-03-14
- Decibel Therapeutics, Inc. depreciation, depletion and amortization for fiscal 2022 was $1.50M, a 7.14% increase from fiscal 2021.
- Decibel Therapeutics, Inc. depreciation, depletion and amortization for fiscal 2021 was $1.40M, a 12.50% decline from fiscal 2020.
- Decibel Therapeutics, Inc. depreciation, depletion and amortization for fiscal 2020 was $1.60M.
| Period end | Depreciation, Depletion and Amortization 12 month |
|---|---|
| 2022-12-31 | $1.50M 10-K · filed 2023-03-14 |
| 2021-12-31 | $1.40M 10-K · filed 2023-03-14 |
| 2020-12-31 | $1.60M 10-K · filed 2022-03-18 |